Prediction of Efficacy for Atezolizumab/Bevacizumab in Unresectable Hepatocellular Carcinoma with Hepatobiliary-Phase Gadolinium Ethoxybenzyl-Diethylenetriaminepentaacetic Acid MRI.
Hideki KunichikaKiyoyuki MinamiguchiTetsuya TachiiriKozo ShimizuRyosuke TaijiAya YamadaRyota NakanoMariko IrizatoSatoshi YamauchiAki MarugamiNagaaki MarugamiHayato KishidaHiroyuki NakagawaMegumi TakewaKen KageyamaAkira YamamotoEisuke UeshimaKeitaro SofueRyuichi KitaHiroyuki KurakamiToshihiro TanakaPublished in: Cancers (2024)
Quantitative analysis using CV in the HBP of Gd-EOB-DTPA-MRI may be useful for predicting tumor progression for atezolizumab/bevacizumab therapy.